Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Asset Utilization Ratio (2024 - 2025)

Silence Therapeutics' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 98.52% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 98.52%, while the annual FY2025 figure was 0.0, 98.75% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.0 at Silence Therapeutics, down from 0.17 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.27 in Q4 2024 and bottomed at 0.0 in Q4 2025.